These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 9067710

  • 1. The utility of a midcycle follicle-stimulating hormone boost in addition to human chorionic gonadotropin for timing of follicle aspiration in unstimulated in vitro fertilization cycles.
    Lindheim SR, Sauer MV, Francis MM, Macaso T, Lobo R, Paulson RJ.
    Gynecol Obstet Invest; 1997; 43(2):76-8. PubMed ID: 9067710
    [Abstract] [Full Text] [Related]

  • 2. Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience.
    Paulson RJ, Sauer MV, Lobo RA.
    J Assist Reprod Genet; 1994 Jan; 11(1):28-32. PubMed ID: 7949832
    [Abstract] [Full Text] [Related]

  • 3. The significance of elevated early follicular-phase follicle stimulating hormone (FSH) levels: observations in unstimulated in vitro fertilization cycles.
    Lindheim SR, Sauer MV, Francis MM, Macaso TM, Lobo RA, Paulson RJ.
    J Assist Reprod Genet; 1996 Jan; 13(1):49-52. PubMed ID: 8825167
    [Abstract] [Full Text] [Related]

  • 4. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer.
    Kreiner D, Droesch K, Itskovitz J, Liu HC, Navot D, Rosenwaks Z.
    J In Vitro Fert Embryo Transf; 1988 Oct; 5(5):265-7. PubMed ID: 3148022
    [Abstract] [Full Text] [Related]

  • 6. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, Rosenwaks Z.
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [Abstract] [Full Text] [Related]

  • 7. A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques.
    Zelinski-Wooten MB, Hutchison JS, Hess DL, Wolf DP, Stouffer RL.
    Hum Reprod; 1998 Mar; 13(3):554-60. PubMed ID: 9572409
    [Abstract] [Full Text] [Related]

  • 8. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 9. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome.
    Loumaye E, Engrand P, Howles CM, O'Dea L.
    Fertil Steril; 1997 May; 67(5):889-99. PubMed ID: 9130895
    [Abstract] [Full Text] [Related]

  • 10. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
    Agrawal R, Conway GS, Engmann L, Bekir JS, Jacobs HS.
    Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
    [Abstract] [Full Text] [Related]

  • 11. In vitro fertilization: determination of follicular maturation for timing of human chorionic gonadotropin administration.
    Casper RF, Armstrong DT, Brown SE, Daniel SA, Yuzpe AA, Erskine H.
    Fertil Steril; 1987 Feb; 47(2):345-9. PubMed ID: 3102289
    [Abstract] [Full Text] [Related]

  • 12. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ, Yang HY, Lin JJ, Chen X, Ye BL.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group.
    Hum Reprod; 1998 Nov; 13(11):3023-31. PubMed ID: 9853849
    [Abstract] [Full Text] [Related]

  • 14. Follicular and estradiol parameters that improve success with natural cycle in vitro fertilization.
    DiMattina M, Gordon JD, Botes A, Celia G, Payson M, Graves-Herring J.
    J Reprod Med; 2014 Nov; 59(5-6):267-73. PubMed ID: 24937968
    [Abstract] [Full Text] [Related]

  • 15. The utility of serum progesterone and inhibin A for monitoring natural-cycle IVF-ET.
    Lindheim SR, Chang PL, Vidali A, Ferin M, Sauer MV.
    J Assist Reprod Genet; 1998 Oct; 15(9):538-41. PubMed ID: 9822981
    [Abstract] [Full Text] [Related]

  • 16. Factors affecting pregnancy success of human in-vitro fertilization in unstimulated cycles.
    Paulson RJ, Sauer MV, Francis MM, Macaso T, Lobo RA.
    Hum Reprod; 1994 Aug; 9(8):1571-5. PubMed ID: 7989524
    [Abstract] [Full Text] [Related]

  • 17. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M, Kiani K, Ghasemi A, Rastegar F, Nabavi M.
    Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
    [Abstract] [Full Text] [Related]

  • 18. Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program.
    Droesch K, Muasher SJ, Kreiner D, Jones GS, Acosta AA, Rosenwaks Z.
    Fertil Steril; 1988 Sep; 50(3):451-6. PubMed ID: 3137100
    [Abstract] [Full Text] [Related]

  • 19. Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration.
    Propst AM, Hill MJ, Bates GW, Palumbo M, Van Horne AK, Retzloff MG.
    Fertil Steril; 2011 Oct; 96(4):898-904. PubMed ID: 21839437
    [Abstract] [Full Text] [Related]

  • 20. The empty follicle syndrome: a pharmaceutical industry syndrome.
    Zegers-Hochschild F, Fernández E, Mackenna A, Fabres C, Altieri E, Lopez T.
    Hum Reprod; 1995 Sep; 10(9):2262-5. PubMed ID: 8530648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.